Harpoon Therapeutics Appoints Natalie Sacks Chief Medical Officer

Natalie Sacks has joined Harpoon Therapeutics as chief medical officer. Sacks comes to South San Francisco, CA-based Harpoon from Aduro Biotech (NASDAQ: [[ticker:ADRO]]) where she was chief medical officer. Harpoon, which develops cancer immunotherapies, raised $45 million in Series B funding last year as it worked to advance its drug programs toward clinical trials. The company says it expects to file for FDA clearance “in the near future” to start human tests of HPN536, a potential treatment for solid tumors.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.